+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibitory effect of amlexanox on asthmatic attacks in an aspirin sensitive asthmatic



Inhibitory effect of amlexanox on asthmatic attacks in an aspirin sensitive asthmatic



Nihon Kyobu Shikkan Gakkai Zasshi 30(6): 1180-1185



The anti-allergic action of amlexanox is reported to be associated with inhibition of the release of LTC4, LTD4 and histamine, and with antagonistic activity on leukotrienes. The patient was a 18-year-old female who had suffered from bronchial asthma since the age of fifteen. We diagnosed the case as aspirin sensitive asthma because of development of a severe asthmatic attack with syncope after oral administration of an analgesic for treatment of a common cold at the age of seventeen. She also had sensitivity to toothpaste. Three-minute aerosol inhalation challenge with 0.1, 1 and 10% solution of sulpyrine was performed as a stepwise increment at 20 minutes intervals. This inhalation test was positive and it evoked simultaneous increases of LTC4, LTD4 and histamine in the peripheral blood. Since the commencement of oral administration of 150 mg per day of amlexanox, the patient has had no attacks for about 8 months. In the second inhalation test, premedication with amlexanox elevated the threshold of sulpyrine and inhibited the release of LTC4, LTD4 and histamine. We report that amlexanox was of use to control asthmatic attacks in this aspirin-sensitive asthmatic patient.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040450990

Download citation: RISBibTeXText

PMID: 1507696


Related references

Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clinical & Experimental Allergy. 25(1): 38-40, 1995

Late onset asthmatic response following bronchoprovocation test with lysine-aspirin in aspirin-sensitive asthmatic patients. Allergy 56(Suppl. 68): 49, 2001

Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen. British Medical Journal 2(6081): 231-232, 1977

Aspirin-Sensitive Asthma: Abnormal Platelet Response to Drugs Inducing Asthmatic Attacks. International Archives of Allergy and Immunology 78(4): 438-448, 1985

Enhanced serum neutrophil chemotactic activity was noted in both early and late asthmatic responses during lysine-aspirin bronchoprovocation test in ASA-sensitive asthmatic patients. Journal of Korean Medical Science 18(1): 42-47, 2003

Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications. International Archives of Allergy and Applied Immunology 78(4): 438-448, 1985

Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects. Thorax 51(1): 64-70, 1996

Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways. American Journal of Respiratory and Critical Care Medicine 156(5): 1384-1389, 1997

Inhibitory effect of TMK-688 on late asthmatic responses as well as T-cell and eosinophilic infiltration in guinea pigs with asthmatic reactions. International Journal of Immunopharmacology 22(2): 123-130, 2000

Increased serum IgE antibodies in institutionalized asthmatic children after a transient return home. The role of house dust mite allergens in the home as a trigger of asthmatic attacks in mite-sensitive patients. Annals of Allergy 57(4): 249-252, 1986

Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment. Journal of Allergy and Clinical Immunology 71(6): 560-567, 1983

Improvement in aspirin sensitive asthmatic subjects after rapid aspirin de sensitization and aspirin maintenance treatment. Journal of Allergy & Clinical Immunology 71(6): 560-567, 1983

Expression of COX and COX2 on aspirin-sensitive and non-aspirin-sensitive asthmatic and normal bronchial mucosa. Journal of Allergy & Clinical Immunology 97(1 PART 3): 318, 1996

The role of the secondary or precipitating causes of asthmatic attacks in the management of the asthmatic patient. Diseases of the Chest 32(4): 447-454, 1957

Role of secondary causes or those precipitating asthmatic attacks in the treatment of the asthmatic patient. Revista Clinica Espanola 73(2): 106-112, 1959